Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoma, with different clinical manifestation and prognosis. The International Prognostic Index (IPI), an index designed during the prerituximab era for aggressive lymphoma, showed variable values in the prediction of patient clinic...
Saved in:
| Main Authors: | Qing Shi, Rong Shen, Chao-Fu Wang, Xing Fan, Ying Qian, Bin-Shen Ou-Yang, Yan Zhao, Christophe Leboeuf, Anne Janin, Shu Cheng, Li Wang, Wei-Li Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/7960907 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated serum IL-10/IL-6 ratio as a novel biomarker for secondary central nervous system lymphoma and poor prognosis in DLBCL
by: Jingjing Wen, et al.
Published: (2025-08-01) -
Regulation and therapy: the role of ferroptosis in DLBCL
by: Yifan Wang, et al.
Published: (2025-01-01) -
Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression
by: Jiaxing Guo, et al.
Published: (2025-05-01) -
Biomedical informatics analysis has revealed a novel hub gene of the HBx in the pathogenesis and progression of DLBCL
by: Ying Zhang, et al.
Published: (2025-09-01) -
High expression of SMPD4 promotes liver cancer and is associated with poor prognosis
by: Rongyue Wang, et al.
Published: (2025-04-01)